Kathleen D Faulkenberg
Overview
Explore the profile of Kathleen D Faulkenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brooksbank J, Faulkenberg K, Tang W, Martyn T
Curr Treat Options Cardiovasc Med
. 2023 Apr;
25(5):93-110.
PMID: 37077616
Purpose Of Review: To examine the emerging data for novel strategies being studied to improve use and dose titration of guideline-directed medical therapy (GDMT) for patients with heart failure (HF)....
2.
Olt C, Faulkenberg K, Hsich E
J Heart Lung Transplant
. 2021 May;
40(9):863-871.
PMID: 34006449
This in-depth review discusses cannabis as it relates to heart transplantation and the growing dilemma of legalization around the world creating disparities in transplant candidacy. One will learn about two...
3.
Martyn T, Faulkenberg K, Albert C, Ilgiovine Z, Randhawa V, Donnellan E, et al.
J Card Fail
. 2020 Dec;
27(3):368-372.
PMID: 33358957
Background: Prior study has demonstrated that transitioning patients in acutely decompensated heart failure with a low cardiac output directly from intravenous (i.v.) vasoactive (ie, vasodilators or inotropes) drugs to sacubitril-valsartan...
4.
Martyn T, Faulkenberg K, Yaranov D, Albert C, Hutchinson C, Menon V, et al.
J Am Coll Cardiol
. 2019 Nov;
74(18):2326-2327.
PMID: 31672191
No abstract available.
5.
West L, Williams J, Faulkenberg K
Curr Treat Options Cardiovasc Med
. 2019 Sep;
21(10):59.
PMID: 31506885
Purpose Of Review: A multidisciplinary approach is vital to reduce mortality and hospitalizations in patients with heart failure. As members of the multidisciplinary team, pharmacists are uniquely positioned to care...
6.
Hellenbart E, Faulkenberg K, Finks S
Vasc Health Risk Manag
. 2017 Sep;
13:325-342.
PMID: 28860793
Direct oral anticoagulants (DOACs) are recognized by evidence-based treatment guidelines as the first-line option for the treatment of venous thromboembolism and prevention of stroke and systemic embolism in nonvalvular atrial...
7.
Faulkenberg K, Beavers J, Finks S
Ann Pharmacother
. 2015 Dec;
50(2):141-51.
PMID: 26681442
Objective: To evaluate direct comparisons of bivalirudin versus unfractionated heparin (UFH) as anticoagulants during ST-segment elevation myocardial infarction (STEMI) in patients undergoing primary percutaneous coronary intervention (PPCI). Data Sources: Relevant...